Clonal evolution in a patient with secondary myelodysplastic syndrome.

被引：0
|
作者：
Podroma, A
Sanmugarajah, J
Yudelman, I
Macera, MJ
Zeng, R
Babu, A
机构：
[1] Lenox Hill Hosp, Dept Med, New York, NY 10021 USA
[2] Wyckoff Heights Med Ctr, Dept Med, Div Med & Mol Genet, Brooklyn, NY USA
来源：
AMERICAN JOURNAL OF HUMAN GENETICS | 2003年 / 73卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
319
引用
收藏
页码：224 / 224
页数：1
相关论文
共 50 条
  • [21] Dynamics of clonal evolution in myelodysplastic syndromes
    Hideki Makishima
    Tetsuichi Yoshizato
    Kenichi Yoshida
    Mikkael A Sekeres
    Tomas Radivoyevitch
    Hiromichi Suzuki
    Bartlomiej Przychodzen
    Yasunobu Nagata
    Manja Meggendorfer
    Masashi Sanada
    Yusuke Okuno
    Cassandra Hirsch
    Teodora Kuzmanovic
    Yusuke Sato
    Aiko Sato-Otsubo
    Thomas LaFramboise
    Naoko Hosono
    Yuichi Shiraishi
    Kenichi Chiba
    Claudia Haferlach
    Wolfgang Kern
    Hiroko Tanaka
    Yusuke Shiozawa
    Inés Gómez-Seguí
    Holleh D Husseinzadeh
    Swapna Thota
    Kathryn M Guinta
    Brittney Dienes
    Tsuyoshi Nakamaki
    Shuichi Miyawaki
    Yogen Saunthararajah
    Shigeru Chiba
    Satoru Miyano
    Lee-Yung Shih
    Torsten Haferlach
    Seishi Ogawa
    Jaroslaw P Maciejewski
    Nature Genetics, 2017, 49 : 204 - 212
  • [22] MYELODYSPLASTIC SYNDROMES - CLONAL ORIGIN AND EVOLUTION
    MUFTI, JG
    JOURNAL OF MEDICAL GENETICS, 1988, 25 (02) : 130 - 130
  • [23] Convergent Clonal Evolution of Signaling Gene Mutations Is a Hallmark of Myelodysplastic Syndrome Progression
    Menssen, Andrew J.
    Khanna, Ajay
    Miller, Christopher A.
    Srivatsan, Sridhar Nonavinkere
    Chang, Gue Su
    Shao, Jin
    Robinson, Joshua
    O'Laughlin, Michele
    Fronick, Catrina C.
    Fulton, Robert S.
    Brendel, Kimberly
    Heath, Sharon E.
    Saba, Raya
    Welch, John S.
    Spencer, David H.
    Payton, Jacqueline E.
    Westervelt, Peter
    Dilpersio, John F.
    Link, Daniel C.
    Schuelke, Matthew J.
    Jacoby, Meagan A.
    Duncavage, Eric J.
    Ley, Timothy J.
    Walter, Matthew J.
    BLOOD CANCER DISCOVERY, 2022, 3 (04): : 330 - 345
  • [24] Clinical trial of paricalcitol in myelodysplastic syndrome.
    Koeffler, HP
    O'Kelly, J
    Aslanian, N
    BLOOD, 2004, 104 (11) : 264B - 264B
  • [25] Pentasomy 8 in pediatric myelodysplastic syndrome.
    Wu, S
    Wong, W
    AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (04) : 72 - 72
  • [26] Genomic methylation analysis of myelodysplastic syndrome.
    Futscher, BF
    Holtan, NS
    Munoz-Rodriguez, JL
    Nouzova, M
    List, AF
    BLOOD, 2002, 100 (11) : 373A - 373A
  • [27] Association of relapsing polychondritis and myelodysplastic syndrome.
    Salahuddin, N
    Lunde, JH
    Cooper, SM
    Libman, BS
    ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S230 - S230
  • [28] Chromosome aberrations in myelodysplastic/MDS syndrome.
    Haus, O
    KotlarekHaus, S
    Makowska, I
    Potoczek, S
    Czarnecka, M
    CYTOGENETICS AND CELL GENETICS, 1997, 77 (1-2): : P315 - P315
  • [29] MYELODYSPLASTIC SYNDROME. THERAPEUTIC ROLE OF AZACITIDINE
    Eguizabal Lorea, Arteche
    Ros Fernando, Marcotegui
    Moreno Fernando, Becerril
    Arnaiz Joana, Gonzalez
    ATENCION FARMACEUTICA, 2009, 11 (03): : 151 - +
  • [30] Intravenous bolus topotecan in myelodysplastic syndrome.
    Seiter, K
    Liu, DL
    Feldman, E
    Sadan, S
    Kancherla, R
    Ahmed, T
    BLOOD, 2000, 96 (11) : 264B - 264B
12345